1. Introduction
===============

In 2009, the Institute of Medicine (IOM) updated the weight gain recommendations during pregnancy, ranging from 11.5 to 16 kg (from 25 to 35 lb) for women with normal weight.^\[[@R1]\]^ Excessive pregnancy weight gain might increase risk of maternal and perinatal morbidity, such as gestational hypertension (pregnancy-induced hypertension: PIH),^\[[@R2],[@R3]\]^ preeclampsia,^\[[@R2],[@R4],[@R5]\]^ cesarean delivery,^\[[@R2],[@R6]\]^ macrosomia,^\[[@R2],[@R7]--[@R9]\]^ low Apgar scores,^\[[@R6]\]^ hypoglycemia,^\[[@R6],[@R7]\]^ admission to the neonatal intensive care unit,^\[[@R6]\]^ prolonged hospital stays of neonates,^\[[@R6]\]^ and childhood obesity.^\[[@R9]\]^ In addition to this, excessive pregnancy weight gain also increases the risk of gestational diabetes mellitus (GDM),^\[[@R10]\]^ resulting in deleterious effect on the pregnancy outcome.^\[[@R10]--[@R13]\]^ Therefore, avoiding excessive pregnancy weight gain may be a good solution to reduce GDM.^\[[@R12]\]^

Obesity also shows a negative impact on the hemodynamic stability in pregnant women. The hemodynamic changes in obese pregnant women include higher arterial blood pressure, hemoconcentration, and altered cardiac function, resulting in prevalent hypertensive disorders,^\[[@R14]\]^ and subsequently contributing to poor maternal and perinatal outcomes.^\[[@R15]--[@R17]\]^ A recent nationwide population-based retrospective cohort study in Taiwan showed that obesity (hazard ratio \[HR\] 7.21, 95% confidence interval \[CI\] 1.58--32.84) was an independent risk factor for the development of intracranial hemorrhage later among pregnant women.^\[[@R15]\]^ In addition, these hypertensive disorders during pregnancy also increased the risk of placental abruption, small-for-gestational age (SGA) newborns, lower Apgar scores, and perinatal mortality.^\[[@R18]--[@R20]\]^

The previous Taiwan\'s experience has shown that the total pregnancy weight gain should be \<11.5 kg among women with normal weight and within 10 kg for women with overweight, because the risk of macrosomia might increase 9-fold (odds ratio \[OR\] 9.63, 95% CI 1.76--52.74),^\[[@R21]\]^ which subsequently contributed to an increased risk for adverse maternal and neonatal outcome.^\[[@R21]--[@R24]\]^ The previous study by D'Angelo et al have suggested that women may benefit from targeted interventions during the preconception and conception periods, which may promote positive maternal and infant health behaviors, experiences, and reproductive outcomes.^\[[@R25]\]^ On the other hand, pregnant women with gestational gain below the IOM guidelines might be at higher risk for placental abruption, SGA newborns, and low birth weight neonates.^\[[@R23],[@R26]\]^ However, the value of preventive strategy for adequate pregnancy weight gain in Taiwan is still unclear. Thus, we conducted this retrospective cohort study, which enrolled healthy mothers who participated in an individual 15-minute dietary and lifestyle education program in one of the medical school-associated hospitals in Taiwan.

2. Materials and methods
========================

In this retrospective cohort study, we provided health education on various prenatal topics and subsequently monitored body weight gain during the whole course of their pregnancy. The study was conducted over a 4-year period from January 2011 through December 2014 in pregnant women at the National Yang Ming University Hospital in Taiwan. Approval for the study was obtained from the hospital\'s ethics committee, and informed consent was obtained from all patients (YMUH Institutional Review Board 2010A029). All pregnant women who began prenatal care (the first antenatal visit) at our hospital were screened to determine whether they were eligible for the study. In addition to the perinatal care program provided by Taiwan Health Promotion Administration, Ministry of Health and Welfare, all pregnant women participated in an individual 15-minute dietary and lifestyle education program conducted by physicians and nurse staff at every clinic visit. This program was a free couple (pregnant women and their spouses)-specific dietary and lifestyle intervention, which differed from the traditional education programs for general prenatal topics during pregnancy (group containing 10--15 couples). The program consisted of a total of 10 classes, 3 of them in the first 20 weeks of gestation, 4 between 20 and 30 weeks and 4 after the 30 weeks of gestation. The contents of the classes focused on the dietary education, including essential nutrition during pregnancy, such as essential amino acids, ferrum, folic acid, and trace elements supplementation, and calorie calculation of food, and life-style education, including exercise and rest. Body weight was recorded every week. This mandatory procedure marked the official beginning of prenatal care in our hospital. Pre-pregnancy weight, height, and body mass index (BMI, weight (kg)/height^2^ (m)) were based on health care provider assessment, which was documented at the first antenatal visit. Total weight gained during pregnancy, including the patient\'s BMI, was determined.

Inclusion criteria included singleton vertex births, healthy pregnant women with normal body weight who received regular prenatal care and delivered at our hospital, signed informed consent by the patient. Normal weight was calculated as a pre-pregnancy BMI between 18.5 and 24.9.

Exclusion criteria included pregnant women who had fetal anomalies, diabetes mellitus, chronic hypertension, preterm delivery of less than 34 weeks, which might underestimate the influence on changes in maternal weight, incomplete data on other variables of interest, and elective cesarean delivery due to malpresentation, placenta previa, previous cesarean delivery or a history of uterine surgery. The flow chart that allocated patients into different groups is shown in Figure [1](#F1){ref-type="fig"}.
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Pregnancy weight gain was based on the IOM guidelines and was separated into 3 groups: below IOM guidelines (\<11.5 kg); within IOM guidelines (11.5--16 kg, normal controls); and above IOM guidelines (\>16 kg).

The following adverse maternal and perinatal outcomes were examined: GDM, preeclampsia, PIH, abnormal labor, postpartum hemorrhage, fourth-degree laceration, cesarean delivery, macrosomia (birth weight of 4500 g or more), nonreassuring fetal status, Apgar score of \<7 at 1 minute, meconium aspiration, preterm births, and low birth weight (birth weight 2500 g or less). Medical costs for hospitalization during delivery were recorded and analyzed. Abnormal labor included prolongation, protraction, and arrest disorders. Classification of the fetal heart rate (FHR) tracings was based on the 3-tier classification system according to the American College of Obstetricians and Gynecologists (ACOG).^\[[@R27]\]^ Category 2 tracings were considered indeterminate. This category required evaluation and surveillance and possibly other tests to ensure fetal health. Category 3 tracings were considered abnormal and required prompt evaluation. Vaginal delivery was categorized as normal spontaneous vaginal delivery (NSD) or operative vaginal delivery with vacuum and/or forceps (instrument delivery).

We used SAS version 9.2 (SAS institute Inc, Cary, NC) for all analyses to account for the complex sample design. Descriptive statistics are presented as the means and standard deviation or percentages. Pearson's chi-square tests were used for categorical variables. Medical cost comparisons of maternal and perinatal outcomes were analyzed by the generalized linear model. The risks of maternal and perinatal complications were presented as ORs using logistic regression according to the following groups: pregnancy weight gain, pre-pregnancy weight, weight at delivery, weight change, pre-pregnancy BMI, BMI at delivery, and BMI change. A *P* value of less than .05 was regarded as statistically significant.

3. Results
==========

Of the 1147 pregnant women who met study criteria, 19.27% had a pregnant weight gain of less than 11.5 kg (below IOM guidelines), 47.43% had a pregnancy weight gain within 11.5 to 16 kg (within IOM guidelines), and 33.30% had a pregnancy weight gain of more than 16 kg (above IOM guidelines). Among the 3 groups, there were statistically significant differences in pre-pregnancy weight, weight at time of delivery, BMI at time of delivery, maternal and perinatal complications, and perinatal birth weight (Table [1](#T1){ref-type="table"}). Women with weight gain above IOM guidelines appeared to, be heavier in weight at the time of delivery have higher BMI at time of delivery, have higher maternal and perinatal complication rates. Women with weight gain below IOM guidelines exhibited heavier weight during the pre-pregnancy period, but they exhibited lighter weight at time of delivery, lower BMI at the time of delivery, and low birth weight in newborns. However, in the comparisons of the 3 groups, there was no statistic significance (Table [1](#T1){ref-type="table"}).

###### 

Clinical characteristics.
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Pregnancy outcome in the women with different weight gains is listed in Table [2](#T2){ref-type="table"}. Consistent with the increased risk of maternal complications in women with weight gain above IOM guidelines, these pregnant women had a higher risk of GDM, dysfunction labor, and cesarean delivery. In addition, women with weight gain above IOM guidelines were at increased risk of macrosomia and meconium aspiration. However, among the 3 groups, there was no significant difference in PIH, preeclampsia, postpartum hemorrhage, fourth-degree laceration, macrosomia, category 2/3 FHR tracings, Apgar scores of \<7 at 1 minute, preterm births, and low-birth weight (Table [2](#T2){ref-type="table"}).

###### 

Clinical characteristics and adverse outcomes associated with pregnancy weight gain.
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The generalized linear regression model revealed that the medical costs increased significantly with the following factors: age (*P* = .0338), pregnancy weight gain above IOM guidelines (*P* = .0079), GDM (*P* = .0109), PIH (*P* \< .0001), preeclampsia (*P* = .0152), postpartum hemorrhage (*P* \< .0001), cesarean delivery (*P* \< .0001), macrosomia (*P* = .0062), category 2/3 FHR tracings (*P* \< .0021), meconium aspiration (*P* = .0048), and preterm births (*P* = .0034) (Table [3](#T3){ref-type="table"}). Gestational age (GA), pregnancy weight gain below IOM guidelines, parity, fourth-degree laceration, Apgar scores of \<7 at 1 minute, and low birth weight were not associated with increased medical costs (Table [3](#T3){ref-type="table"}).

###### 

Medical cost comparison of clinical characteristics and adverse outcomes.
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In Table [4](#T4){ref-type="table"}, the significant predictors of adverse maternal and perinatal outcomes included pre-pregnancy weight, weight at the time of delivery, pre-pregnancy BMI, BMI at the time of delivery and changes in BMI according to the logistic regression model. Our results demonstrated that the highest accuracy rate in forecasting maternal complications was 79.0% in BMI at the time of delivery. The highest rate in forecasting neonatal complications was 65.2% in weight at the time of delivery. Moreover, analysis of predictors of maternal complications in pregnancy weight gain revealed that pregnancy weight gain above IOM guidelines (OR 1.65, 95% CI 1.03--1.98) and age (OR 1.08, 95% CI 1.02--1.15) were associated with more maternal complications, whereas parity (OR 0.23, 95% CI 0.12--0.41) and GA (OR 0.50, 95% CI 0.35--0.62) were associated with lower maternal complications. In addition, analysis of predictors of adverse perinatal outcomes revealed that pregnancy weight gain above IOM guidelines (OR 1.45, 95% CI 1.01--1.87), non-NSD (OR 2.85, 95% CI 1.45--3.56) and age (OR 1.06, 95% CI 1.01--1.12) were associated with more perinatal complications, while parity (OR 0.66, 95% CI 0.45--0.91) and GA (OR 0.65, 95% CI 0.56--0.77) were associated lower perinatal outcomes (Table [4](#T4){ref-type="table"}).

###### 

Predicting model using logistic regression by maternal weight and body mass index.
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The operative vaginal delivery (instrument delivery) rate increased in women with pregnancy weight gain above IOM guidelines compared with the other 2 groups (Table [5](#T5){ref-type="table"}). Moreover, greater medical expenses were needed for operative vaginal delivery compared with NSD (new Taiwan dollars \[NTD\] 23359.98 ± 614.21 vs 22740.40 ± 779.33, *P* = .0124). However, there was no significant difference in clinical adverse outcomes between operative vaginal delivery and NSD groups (data not shown).

###### 

Risk of instrument delivery associated with pregnancy weight gain by Pearson\'s chi-square test.
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4. Discussion
=============

Through adequate weight control, pregnant women with pregnancy weight gain within IOM guidelines have fewer maternal complications and fewer perinatal complications compared with women with pregnancy weight gain above or below IOM guidelines.^\[[@R21],[@R22],[@R26]\]^ However, maintaining appropriate maternal weight may not be easy, as demonstrated by the frequency of excessive pregnancy weight gain. It was previously demonstrated by Johnson et al that nearly three-fourths of pregnant women exhibited weight gain above IOM guidelines.^\[[@R2]\]^ Our study demonstrated a feasible modality of achieving adequate weight control using individual 15-minutes dietary and lifestyle education counseling. Of 1147 pregnancies, nearly half of the pregnant women were able to maintain their body weight gain within IOM guidelines.

Although there is ample evidence that pregnant weight gain is associated with adverse maternal and neonatal outcomes, the subjects in these studies were overweight or obese for the most part.^\[[@R2]--[@R8]\]^ The strength of our study is that the pre-pregnancy body weight in the study population is within normal limits.

This study population also reduced the impact of pre-pregnancy obesity on the outcomes. The results of our study showed that weight gain above IOM guidelines significantly increased not only maternal and perinatal complications but also medical costs. Our study shows the importance of active intervention not only in counseling to control overweight or obesity but also in women exhibiting a normal weight during pregnancy.^\[[@R28]\]^ Indeed, adequate weight control during pregnancy significantly reduces medical costs and may also lower the risk of persistent postpartum obese diathesis.^\[[@R29]\]^ Interestingly, 1 study reported that maternal pregnancy weight gain was also associated with offspring childhood obesity during a 3-year follow-up period.^\[[@R9]\]^ Thus, it is important for both normal and obese pregnant women to conduct preconception counseling and exhibit optimal weight gain to reduce maternal and perinatal complications and medical costs.^\[[@R30]\]^

In our current study, women with pregnancy weight gain above IOM guidelines presented with similar PIH and pre-eclampsia as those within and below IOM guidelines. The possible reason is unknown, but normal weight before pregnancy might be one of the causes.

Low Apgar scores are more frequent in neonates of pregnant women with weight gain above IOM guidelines than in those of pregnant women with weight gain within IOM guidelines (OR 1.33, 95% CI 1.01--1.76).^\[[@R6]\]^ In our study, newborns of women with weight gain above IOM guidelines had lower Apgar scores at 1 minute but did not have lower Apgar scores at 5 minutes. The possible reason is unknown, but lower Apgar scores were correlated with more category 2/3 FHR tracings that revealed fetal distress and abnormal labor in women with pregnancy weight gain above IOM guidelines; these events subsequently resulted in the frequent use of instrument and caesarean deliveries. The perinatal complications are likely to be due to multiple mechanisms and many unknown or subclinical metabolic changes in these pregnant women with weight gain above IOM guidelines are always present.^\[[@R6]\]^ Stotland\'s study demonstrated an increased risk of neonatal hypoglycemia with excessive gestational gain.^\[[@R6]\]^ Obese women had signs of adipocyte recruitment and maintenance of adiponectin levels, significantly contributing to gestation insulin resistance, even though these women all remained normoglycemic.^\[[@R31]\]^

Using the logistic regression model, our results demonstrated that pregnancy weight gain above IOM guidelines might increase both maternal (OR 1.65, 95% CI 1.03--1.98) and perinatal complications (OR 1.45, 95% CI 1.01--1.87). After further analysis, we found that the highest accuracy rate in forecasting maternal and perinatal complications was BMI at the time of delivery (79.0%) and weight at the time of delivery (65.2%), respectively. Although there are different definitions in weight and BMI, both suggest that the absolute weight status, even according to BMI or final body weight at the time of delivery, is of paramount importance, suggesting that targeted intervention in weight control during the course of pregnancy is useful. Recent studies have shown that interventions in body weight of women who plan to get pregnant might further decrease the incidence of adverse outcomes in pregnancy.^\[[@R32]--[@R34]\]^ Many studies also showed that targeted efforts and effective interventions during pregnancy can improve weight gain trajectories and overall health.^\[[@R35]--[@R39]\]^

This study has some limitations that might affect the medical costs and adverse outcomes that occur with maternal pregnant weight gain. First, we did not recruit underweight, overweight or obese women before conception. However, this aspect is also the strength of our study.

Second, the medical expenditure was limited only to that at the time of delivery. The costs of the preventive strategy used in the current study to educate and care the women to maintain adequate weight control were not included in the final calculation of the expenses. If these expenses were taken into consideration, the medical costs (the concealed cost was NTD 3000 in each time) were even higher. However, we believed that these concealed costs might be compensated by the concealed costs of complications. The women with instrument-assisted delivery might have a higher risk of the development of pelvic organ prolapse and/or urinary incontinence than those with NSD.^\[[@R40],[@R41]\]^ Moreover, we did not compared the women enrolled in our preventive strategy with those who took only part in traditional perinatal care program.

Third, the compliance of the subjects in our current study was not evaluated. It is highly possible that the compliance of pregnant women differed. Some pregnant women might carry a lot of misbeliefs and did not follow the suggestions offered by this specific dietary and lifestyle intervention program. As shown in the current study, there were still one-third of study subjects (33.3%) who had an excess pregnancy weight gain, suggesting that some women still believed that their babies would be stronger if they were not concerned with the pregnancy weight.

Fourth, the study population was relatively small compared with previous reports, which enrolled 312,412 and 292,568 births, respectively^\[[@R42],[@R43]\]^ Moreover previous studies clearly showed that different races might impact obesity-related neonatal complications of pregnancy. Obese Caucasian women and it younger population had a higher risk to have macrosomic babies and infant complications than obese African-American women and it younger population did, respectively.^\[[@R42],[@R44]\]^ Dr Liu\'s report showed both excessive or insufficient maternal weight gain were associated with increased risks for adverse pregnancy outcomes in Chinese women.^\[[@R43]\]^ However, the above-mentioned study population was based on the "Perinatal Health Care Surveillance System," therefore the relatively heterogeneous population cannot be totally avoided.^\[[@R43]\]^ In addition, the study period was relatively long and medical care might be varied greatly during this time. On the contrary, our study was carried out in a short time and in a population that inhabits a country area free of environmental pollution. In addition, all women received a similar prenatal and perinatal care based on the Taiwan\'s National Health Insurance program^\[[@R45],[@R46]\]^ along with the individual 15-minute dietary and lifestyle education program.

Fifth, adequate nutritional support for pregnant women is an important issue. Adequate protein intake helps pregnant women to maintain their health and performance, but this also affects fetal growth and minimizes adverse outcomes.^\[[@R47]\]^ In addition to this, it is also well-known that specific diets, such as a plant-based protein diet, might fail to provide adequate amounts of essential amino acids.^\[[@R48],[@R49]\]^ Moreover, dietary food intake might vary within a population, according with race or social background, for example, regardless of pregnancy weight gain status. In the current study, the detailed information of food intake was not recorded. Nevertheless, the study subjects all lived in the same area pollution-free country site, were all Taiwanese women, presented homogeneous social background and, all enrolled the same Taiwan\'s healthcare system thus suggesting that the consideration of the potential bias can be neglected.

Finally, in the current study, medical costs were recorded as a whole without independently accounting for the maternal and neonatal components. Based on the fixed payment system for the labor process, which was guided by Taiwan Diagnosis Related Groups,^\[[@R50],[@R51]\]^ regardless of women treated with operative delivery (including caesarean section and instrument-assisted vaginal delivery) or vaginal delivery by Taiwan National Health Insurance Administration, Ministry of Health and Welfare, the cost reduction may be underestimated in the present study. It is clearly shown that costs of instrumental and caesarean deliveries were significantly higher than those of vaginal delivery without spontaneous complications (baseline cost), as shown in Table [3](#T3){ref-type="table"}. The results presented in Table [5](#T5){ref-type="table"} also show that women with pregnancy weight gain above IOM guidelines (\>16 kg) had a significantly increased risk of instrumental delivery.

In conclusion, consistent with previous reports showing the worse outcome in pregnant women with significantly increased gestational weight gains,^\[[@R23],[@R24],[@R52],[@R53]\]^ this study highlights the prospective role of approximate weight gain or even less weight gain during pregnancy, which could lower maternal and neonatal complications in the Taiwanese pregnant women, although the recommendation of the later (gestational weight gain below IOM guidelines) is still conflicted.^\[[@R54]\]^ Health education on various prenatal topics and efforts to decrease body weight gain during pregnancy would be a better strategy to minimize the risk of both maternal and neonatal complications.
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